Cargando…
Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes
Although cystic fibrosis (CF) is recognized as a monogenic disease, due to variants within the CFTR (Cystic Fibrosis Transmembrane Regulator) gene, an extreme clinical heterogeneity is described among people with CF (pwCF). Apart from the exocrine pancreatic status, most studies agree that there is...
Autores principales: | Mésinèle, Julie, Ruffin, Manon, Guillot, Loïc, Corvol, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698440/ https://www.ncbi.nlm.nih.gov/pubmed/36430680 http://dx.doi.org/10.3390/ijms232214205 |
Ejemplares similares
-
Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis
por: Mésinèle, Julie, et al.
Publicado: (2022) -
Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis
por: Ruffin, Manon, et al.
Publicado: (2020) -
SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis
por: Corvol, Harriet, et al.
Publicado: (2018) -
SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation
por: Mercier, Julia, et al.
Publicado: (2022) -
DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
por: Magalhães, Milena, et al.
Publicado: (2017)